20 May 2013
Keywords: nanoparticle, formulation, gsk, compound, nanocarrier, japan, entered
Article | 21 January 2002
NanoCarrier of Japan has entered into an agreement with GlaxoSmithKline to carry out exploratory studies to determine the feasibility
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 January 2002
17 May 2013
© 2013 thepharmaletter.com